Verywell Health on MSN
Overview of neck arthritis (cervical spondylosis)
Neck arthritis is common and affects more than 85% of people over the age of 60. Symptoms of neck arthritis include neck pain ...
Treatment for neck pain includes manual therapy combined with exercise. Manual therapy consists of hands-on techniques used to mobilise or manipulate soft tissues, joints, or nerves. The exercise ...
Emirates Drug Establishment Approves Tapinarof Cream 1%, A New Treatment For Plaque Psoriasis In Adults And Atopic Dermatitis ...
Angela Read thought she had a sinus infection, soon she discovered her condition was much more serious. She's grateful to the far-away team that treated her.
Woman's World on MSN
What rotator cuff pain feels like and the stretches that ease shoulder stiffness
Saddled with shoulder discomfort or struggling to lift your arm? A rotator cuff tear could be causing your pain. "The rotator ...
The National on MSN
Soundstorm 2025 review: Cardi B shows she’s ready to take on the world with Saudi festival’s best set
Music festival features performances by Post Malone, Pitbull, Halsey and others ...
Everyday Health on MSN
Rheumatoid Arthritis and Hair Loss: Causes and Remedies
Rheumatoid arthritis (RA) may cause hair loss due to medications, other autoimmune diseases, or stress. Learn about the causes and remedies to manage hair thinning linked to RA.
Doctors caution that constant screen time is reshaping posture, overloading the neck and spine, and speeding up long-term ...
Ease tight muscles and improve mobility with these simple neck stretches that melt away tension and help you move freely again.
I call it the New York prescription. A stimulant for the day (Adderall, Ritalin, Phentermine, many others) and a sedative for ...
Everyday Health on MSN
Everyday Activities Can Trigger Back Pain Flares — but They Don’t Cause Lasting Damage
A new study suggests everyday movements may cause temporary back flares, but not long-term damage — so you can stay active without fear.
Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results